Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Pediatrix Medical (MD) Long-Term Debt Issuances (2019 - 2022)

Pediatrix Medical (MD) reported Long-Term Debt Issuances of $650.0 million for Q1 2022, up 30.0% on a QoQ basis from $500.0 million in Q1 2019.

Pediatrix Medical (MD) has 2 years of Long-Term Debt Issuances data on file, last reported at $650.0 million in Q1 2022.

  • Quarterly Long-Term Debt Issuances changed N/A year-over-year to $650.0 million in Q1 2022, while the trailing twelve-month figure through Dec 2022 was $650.0 million (changed N/A YoY) and the FY2022 annual result came in at $650.0 million, changed N/A from the prior year.
  • Long-Term Debt Issuances grew to $650.0 million in Q1 2022 per MD's latest filing, from $500.0 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $650.0 million in Q1 2022 and bottomed at $500.0 million in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn -
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn 14.00 Mn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn 1.26 Bn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn 250.00 Mn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn -
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn -
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn 582.91 Mn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn 135.48 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn -
10 Pediatrix Medical 1.74 Bn 1.41 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2022 650.00 Mn
Mar 31, 2022 650.00 Mn
Mar 31, 2019 500.00 Mn
Mar 31, 2019 500.00 Mn